The Impact of Poloxamer 407 on the Ultrastructure of the Liver and Evidence for Clearance by Extensive Endothelial and Kupffer Cell Endocytosis

Toxicologic Pathology

Volumn 39, Issue 2, 2011, Pages 390-397

  Warren, Alessandra ^a   Benseler, Volker ^b,c   Cogger, Victoria C ^a   Bertolino, Patrick ^b   le Couteur, David G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

electron microscopy; endocytosis; hepatic sinusoid; hepatic stellate cell; Kupffer cell; mice; P407; poloxamer 407; sinusoidal endothelial cell

Indexed keywords

LIPOPROTEIN; POLOXAMER;

ARTICLE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOTHELIUM CELL; FENESTRATION; HYPERLIPIDEMIA; KUPFFER CELL; LIVER CELL; LIVER SINUSOIDAL ENDOTHELIAL CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE;

ANIMALS; ENDOCYTOSIS; ENDOTHELIAL CELLS; HEPATIC STELLATE CELLS; HEPATOCYTES; HYPERLIPIDEMIAS; KINETICS; KUPFFER CELLS; LIPOPROTEINS; LIVER; MICE; MICE, INBRED STRAINS; MICROSCOPY, ELECTRON; POLOXAMER;

ANIMALIA; MUS;

EID: 79954474986     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310394212     Document Type: Article

References (20)

1. Cogger V. C. Hilmer S. N. Sullivan D. Muller M. Fraser R. Le Couteur D. G. (2006). Hyperlipidemia and surfactants: The liver sieve is a link. Atherosclerosis 189, 273–81.
2. Cogger V. C. Le Couteur D. G. (2009). Fenestrations in the liver sinusoidal endothelial cell. In The Liver: Biology and Pathobiology (Arias I. Wolkoff A. Boyer J. Shafritz D. Fausto N. Alter H. Cohen A., eds.), pp. 387–404. John Wiley, Hokoben NJ
3. Dumortier G. Grossiord J. L. Agnely F. Chaumeil J. C. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23, 2709–28.
4. Fraser R. Dobbs B. R. Rogers G. W. (1995). Lipoproteins and the liver sieve: The role of fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 21, 863–74.
5. Johnston T. P. (2004). The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: A review of findings to date. J Cardiovasc Pharmacol 43, 595–606.
6. Johnston T. P. Coker J. W. Paigen B. J. Tawfik O. (2002). Sex does not seem to influence the formation of aortic lesions in the P-407-induced mouse model of hyperlipidemia and atherosclerosis. J Cardiovasc Pharmacol 39, 404–11.
7. Johnston T. P. Palmer W. K. (1993). Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem Pharmacol 46, 1037–42.
8. Krause M. F. Orlowska-Volk M. Hendrik E. R. Gommers D. Lachmann B. (2000). A new simple method of staining exogenous surfactant in experimental research. Eur Respir J 15, 949–54.
9. Li C. Palmer W. K. Johnston T. P. (1996). Disposition of poloxamer 407 in rats following a single intraperitoneal injection assessed using a simplified colorimetric assay. J Pharm Biomed Anal 14, 659–65.
10. McCuskey R. S. (2008). The hepatic microvascular system in health and its response to toxicants. Anat Rec 291, 661–71.
11. Millar J. S. Cromley D. A. McCoy M. G. Rader D. J. Billheimer J. T. (2005). Determining hepatic triglyceride production in mice: Comparison of poloxamer 407 with Triton WR-1339. J Lipid Res 46, 2023–8.
12. Moghimi S. M. (1999). Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: Applications in cancer drug delivery and imaging. Biochim Biophys Acta 1472, 399–403.
13. Palmer W. K. Emeson E. E. Johnston T. P. (1998). Poloxamer 407-induced atherogenesis in the C57BL/6 mouse. Atherosclerosis 136, 115–23.
14. Rizwan S. B. Dong Y.-D. Boyd B. J. Rades T. Hook S. (2007). Characterisation of bicontinuous cubic liquid crystalline systems of phyantriol and water using cryo field emission scanning electron microscopy. Micron 38, 478–85.
15. Smedsrod B. De Bleser P. J. Braet F. Lovisetti P. Vanderkerken K. Wisse E. Geerts A. (1994). Cell biology of liver endothelial and Kupffer cells. Gut 35, 1509–16.
16. Trout J. J. Viles J. M. (1979a). Cellular changes associated with Triton WR-1339 accumulation in rat hepatocytes. I. Autophagy. Exp Mol Pathol 30, 230–41.
17. Trout J. J. Viles J. M. (1979b). Cellular changes associated with Triton WR-1339 accumulation in rat hepatocytes. II. Lysosomal triton WR-1339 accumulation. Exp Mol Pathol 31, 81–90.
18. Vilaro S. Llobera M. (1988). Uptake and metabolism of Intralipid by rat liver: An electron-microscopic study. J Nutr 118, 932–40.
19. Warren A. Bertolino P. Benseler V. Fraser R. McCaughan G. W. Le Couteur D. G. (2007). Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. J Hepatol 46, 239–46.
20. Warren A. Le Couteur D. G. Fraser R. Bowen D. G. McCaughan G. W. Bertolino P. (2006). T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44, 1182–90.